Digestive System Non-Hodgkin Lymphoma — Trials

Digestive System Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 15%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02420795	Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma	terminated	Phase 1 / Phase 2	16	M.D. Anderson Cancer CenterOTHER	1	Apr 4, 2022	clinicaltrials
NCT01805037	Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas	terminated	Phase 1 / Phase 2	20	Northwestern UniversityOTHER	1	Sep 1, 2021	clinicaltrials